LX-2022 | m-entrepreneurship.com

Product Name :
LX-2022

Search keywords :
Troponin I

drugId :
null

Target Vo:
Troponin I, cardiac muscle

Target Vo Short Name :
TNNI3

Moa_Name:
Troponin I, cardiac muscle gene transference

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
LEXEO Therapeutics

Active Company_Name :
LEXEO Therapeutics

Active Indication_Name:
Cardiomyopathy, Hypertrophic

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
EpCAM Rabbit mAb site
RelB Rabbit mAb site
Ku80 Antibody: Ku80 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to Ku80. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts